Molecular Partners (MOLN) Stock Chart & Stock Price History $3.55 0.00 (-0.11%) Closing price 07/11/2025 03:57 PM EasternExtended Trading$3.62 +0.08 (+2.23%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Molecular Partners Stock Price Performance The Molecular Partners (MOLN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 42.62%, with a year-to-date return of -25.35%. In the past month, the stock has decreased 8.40%, reflecting recent market activity. As of the latest close, Molecular Partners traded at $3.55 with a market cap of $143.17 million and volume of 497 shares. Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.95%1 Month Performance-8.40%3 Month Performance-8.37%Year-To-Date Performance-25.35%1 Year Performance-42.62% MOLN Stock Chart for Sunday, July, 13, 2025 MOLN Chart by TradingView Molecular Partners Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$3.63$3.55-2.18%$3.59$3.59497 shs$143.17 million07/10/2025$3.65$3.63-0.66%$3.60$3.551,050 shs$146.38 million07/09/2025$3.58$3.65+1.93%$3.68$3.583,313 shs$147.35 million07/08/2025$3.61$3.58-0.83%$3.68$3.583,313 shs$144.54 million07/07/2025$3.72$3.61-2.96%$3.76$3.612,184 shs$145.77 million07/04/2025$3.72$3.72$3.76$3.74638 shs$150.20 million07/03/2025$3.80$3.72-2.11%$3.76$3.74638 shs$150.21 million07/02/2025$3.69$3.80+2.98%$3.76$3.74638 shs$153.44 million07/01/2025$3.79$3.69-2.64%$3.84$3.71710 shs$149.00 million06/30/2025$3.70$3.79+2.57%$3.89$3.741,590 shs$153.04 million Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$3.66$3.70+0.85%$3.76$3.637,902 shs$149.20 million06/26/2025$3.69$3.66-0.70%$3.86$3.585,613 shs$147.95 million06/25/2025$3.60$3.69+2.64%$3.71$3.682,505 shs$148.98 million06/24/2025$3.58$3.60+0.42%$3.90$3.503,191 shs$145.17 million06/23/2025$3.68$3.58-2.74%$3.90$3.503,191 shs$144.56 million06/20/2025$3.75$3.68-1.84%$3.89$3.89285 shs$148.62 million06/19/2025$3.75$3.75$3.82$3.82449 shs$151.43 million06/18/2025$3.78$3.75-0.82%$3.82$3.82449 shs$151.43 million06/17/2025$3.85$3.78-1.69%$4.13$3.762,822 shs$152.66 million06/16/2025$3.87$3.85-0.65%$3.95$3.842,375 shs$155.28 million06/13/2025$3.90$3.87-0.74%$4.12$3.682,053 shs$156.29 million06/12/2025$3.64$3.90+7.11%$3.90$3.75797 shs$157.46 million Related Companies Sage Therapeutics Stock Chart Keros Therapeutics Stock Chart Mind Medicine (MindMed) Stock Chart Theravance Biopharma Stock Chart Prime Medicine Stock Chart atai Life Sciences Stock Chart Tyra Biosciences Stock Chart Opthea Stock Chart Taysha Gene Therapies Stock Chart Bicycle Therapeutics Stock Chart Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MOLN) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
